Company news
Relay Therapeutics, Inc. news in 2020
Relay Therapeutics, Inc.'s news releases, calls and decks from 2020, newest first.
Relay Therapeutics Announces a Worldwide License and Collaboration Agreement with Genentech for RLY-1971
December 13, 2020
Relay Therapeutics Reports Third Quarter 2020 Financial Results
November 11, 2020
Relay Therapeutics Announces Dosing of First Patient in First-in-Human Clinical Trial of RLY-4008, a Highly Selective FGFR2 Inhibitor
September 2, 2020
Relay Therapeutics Reports Second Quarter 2020 Financial Results
August 26, 2020
Relay Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
July 19, 2020
Decks in 2020
- Merger or Acquisition (December 2020)
Merger or acquisition · 8 slides · Dec 14, 2020